Definitive Healthcare Corp. (NASDAQ:DH) Receives Average Rating of “Hold” from Analysts

Shares of Definitive Healthcare Corp. (NASDAQ:DH – Get Rating) have been assigned an average rating of “Moderate Buy” from the eight brokerages that are currently covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $14.29.

A number of equities analysts have recently issued reports on the company. Needham & Company LLC reissued a “buy” rating and set a $15.00 target price on shares of Definitive Healthcare in a research note on Friday, February 24th. Barclays cut their price objective on Definitive Healthcare from $11.00 to $10.00 in a research report on Monday. Morgan Stanley reduced their target price on shares of Definitive Healthcare from $18.00 to $17.00 and set an “overweight” rating on the stock in a report on Tuesday, February 28th. Credit Suisse Group decreased their price objective on Definitive Healthcare from $19.00 to $15.00 and set a “neutral” rating on the stock in a report on Friday, February 24th. Finally, Robert W. Baird lowered their target price on shares of Definitive Healthcare from $15.00 to $13.00 in a report on Friday.

Hedge Funds Weigh In On Definitive Healthcare

Large investors have recently added to or reduced their stakes in the company. Ensign Peak Advisors Inc acquired a new stake in shares of Definitive Healthcare in the third quarter valued at approximately $53,000. Captrust Financial Advisors raised its holdings in shares of Definitive Healthcare by 2,358.9% during the second quarter. Captrust Financial Advisors now owns 4,721 shares of the company’s stock valued at $108,000 after acquiring an additional 4,529 shares during the period. US Bancorp DE lifted its holdings in shares of Definitive Healthcare by 81.0% in the first quarter. US Bancorp DE now owns 5,087 shares of the company’s stock valued at $125,000 after purchasing an additional 2,276 shares in the last quarter. PNC Financial Services Group Inc. boosted its position in Definitive Healthcare by 34.6% during the 4th quarter. PNC Financial Services Group Inc. now owns 5,092 shares of the company’s stock worth $56,000 after acquiring an additional 1,309 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank purchased a new position in Definitive Healthcare during the third quarter valued at approximately $81,000.

Definitive Healthcare Trading Down 1.4 %

DH opened at $10.07 on Tuesday. The firm has a market cap of $1.11 billion, a price-to-earnings ratio of -83.91, a price-to-earnings-growth ratio of 29.98 and a beta of 0.51. Definitive Healthcare has a 52 week low of $8.71 and a 52 week high of $30.11. The business’s 50 day moving average is $10.85 and its two-hundred day moving average is $11.71. The company has a quick ratio of 3.12, a current ratio of 3.12 and a debt-to-equity ratio of 0.17.

Definitive Healthcare (NASDAQ:DH – Get Rating) last announced its earnings results on Thursday, February 23rd. The company reported $0.01 EPS for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.02. Definitive Healthcare had a negative net margin of 3.98% and a positive return on equity of 0.23%. The business had revenue of $60.60 million during the quarter, compared to analysts’ expectations of $58.61 million. On average, research analysts predict that Definitive Healthcare will post 0.02 EPS for the current year.

Definitive Healthcare Company Profile

(Get Rating)

Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution.